National Symposium 2018

301 - Medical Marijuana in the United States: 4 Years Later

Apr 18, 2018 7:15am ‐ Apr 18, 2018 9:00am


Credits: None available.

Standard: $40.00
Members: $30.00

Description

Medical marijuana continues to be a hot topic in the U.S. This session reviews regulatory issues for use of medical marijuana in the U.S., dosage forms and pharmacodynamic impact, potential therapeutic effects, potential drug interactions, and consumer safety issues.

Contact hours available until 4/18/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:
• Marijo Johnson – Employee, Fresenius Medical Care

Speaker Disclosure:
• Lora Borgelt – Honoraria, continuing education related to cannabis, PharmCon, Inc.

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Learning Outcome:
Nephrology nurses state an increased comfort in caring for patients with renal disease who also are using medical marijuana, particularly assessments and care planning.

Speaker(s):

Credits Available


Medical Marijuana in the United States: 4 Years Later

You must be logged in and own this session in order to post comments.